or Try an Advanced Search...

    Angina Stocks List

    Symbol Grade Name % Change
    AZN A Astrazeneca PLC -2.44
    MIST D Milestone Pharmaceuticals Inc. -3.51
    LSTA D Lisata Therapeutics, Inc. -2.69
    ALKS F Alkermes plc -1.12
    GILD F Gilead Sciences, Inc. -2.65
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Hypertension Cholesterol Chronic Kidney Disease Coronavirus Depressive Disorder Disease Infection Inflammation Nasdaq 100 Organic Chemistry Respiratory Diseases Schizophrenia Acid Alcohol Anemia Antibiotics Antibodies Asthma Atrial Fibrillation

    Related ETFs - A few ETFs which own one or more of the above listed Angina stocks.

    Symbol Grade Name Weight
    IBBQ C Invesco Nasdaq Biotechnology ETF 12.63
    BIB C ProShares Ultra Nasdaq Biotechnology 8.7
    IBB D iShares Nasdaq Biotechnology Index Fund 8.0
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.77
    BBH C Market Vectors Biotech ETF 7.38
    View all Angina ETFs...
    Compare ETFs
    Compare IBB to BIS Compare IBBQ to BIB Compare IBBQ to BIS

        Angina Stocks Recent News

        Date Stock Title
        May 28 AZN Why Is AstraZeneca Stock Trading Lower On Tuesday?
        May 28 AZN Cellectis Reports Financial Results for First Quarter 2024
        May 28 GILD Gilead Sciences: Seriously Undervalued At Peak Pessimism
        May 28 AZN AstraZeneca, Daiichi Sankyo ADC misses key endpoint in phase 3 lung cancer trial
        May 28 GILD Gilead partnering with Cartography Biosciences to discover cancer therapies
        May 28 GILD Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
        May 28 GILD 2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years
        May 28 LSTA Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
        May 28 ALKS Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
        May 27 GILD Gilead Sciences: Disappointing Fundamentals And Sentiment, But Still Bullish
        May 27 AZN Here's Why Astrazeneca (AZN) is a Strong Growth Stock
        May 27 AZN AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
        May 27 AZN Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
        May 27 AZN AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
        May 27 GILD Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows
        May 26 AZN Wall Street Breakfast: The Week Ahead
        May 26 GILD Wall Street Breakfast: The Week Ahead
        May 25 GILD Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
        May 24 AZN Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
        May 24 AZN AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Hypertension Cholesterol Chronic Kidney Disease Coronavirus Depressive Disorder Disease Infection Inflammation Nasdaq 100 Organic Chemistry Respiratory Diseases Schizophrenia Acid Alcohol Anemia Antibiotics Antibodies Asthma Atrial Fibrillation
        Angina

        Angina, also known as angina pectoris, is chest pain or pressure, usually due to not enough blood flow to the heart muscle.
        Angina is usually due to obstruction or spasm of the coronary arteries. Other causes include anemia, abnormal heart rhythms and heart failure. The main mechanism of coronary artery obstruction is an atherosclerosis as part of coronary artery disease. The term derives from the Latin angere ("to strangle") and pectus ("chest"), and can therefore be translated as "a strangling feeling in the chest".

        More about Angina
        Browse All Tags